At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
BK4556 Gene Editing
Trading 06-14 13:45:44 EDT
507.41
-12.55
-2.41%
High521.27
Low505.26
Vol8.08M
Open518.04
D1 Closing519.96
Amplitude3.08%
Mkt Cap0.00
Tradable Cap0.00
Total Shares0.00
T/O80.06M
T/O Rate--
Tradable Shares0.00
P/B2.358872
ROE--
EPS0.00
52wk High--
52wk Low--
P/E--
Dividend--
Div.Yield--
ROA--
Press Release: Intellia Therapeutics Names Brian Goff to its Board of Directors
Editas Medicine Reports New Safety and Efficacy Data from the RUBY Trial of Reni-cel in 18 Patients with Sickle Cell Disease, Presented at the European Hematology Association (EHA) Annual Congress
Beam Therapeutics Reports Data Highlighting Optimized Manufacturing Process for BEAM-101, an Investigational Base Editing Therapeutic for Sickle Cell Disease